Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Journal of Hematology & Oncology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Jan. 13, 2025
The
tumor
microenvironment
(TME)
is
integral
to
cancer
progression,
impacting
metastasis
and
treatment
response.
It
consists
of
diverse
cell
types,
extracellular
matrix
components,
signaling
molecules
that
interact
promote
growth
therapeutic
resistance.
Elucidating
the
intricate
interactions
between
cells
TME
crucial
in
understanding
progression
challenges.
A
critical
process
induced
by
epithelial-mesenchymal
transition
(EMT),
wherein
epithelial
acquire
mesenchymal
traits,
which
enhance
their
motility
invasiveness
progression.
By
targeting
various
components
TME,
novel
investigational
strategies
aim
disrupt
TME's
contribution
EMT,
thereby
improving
efficacy,
addressing
resistance,
offering
a
nuanced
approach
therapy.
This
review
scrutinizes
key
players
emphasizing
avenues
therapeutically
components.
Moreover,
article
discusses
implications
for
resistance
mechanisms
highlights
current
toward
modulation
along
with
potential
caveats.
Language: Английский
Glioblastoma Drives Protease-Independent Extracellular Matrix Invasion of Microglia
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
31, P. 101475 - 101475
Published: Jan. 9, 2025
Glioblastoma
(GBM)
is
the
most
common
and
lethal
form
of
primary
brain
cancer.
Microglia
infiltration
into
tumor
microenvironment
associated
with
immunosuppression
poor
prognosis.
Improved
physicochemical
understanding
microglia
activation
invasion
may
provide
novel
GBM
therapeutic
strategies
essential
for
improving
long-term
treatment
efficacy.
Here,
we
combine
microfluidic
systems
3-D
collagen
hydrogels
to
systematically
investigate
activation,
invasion,
contractility
cytokine
secretion
in
response
GBM-microglia
crosstalk.
inflammatory
biomolecules
significantly
promote
3D
microglia.
Interestingly,
not
affected
by
inhibitors
MMP
activity
or
cellular
glycolysis.
In
contrast,
ROCK-pathway
inhibition
impedes
invasion.
Infrared
microscopy
analyses
show
that
conditioned
media
does
alter
lipid
content.
Further,
resulted
increased
hydrogel
contraction,
suggesting
importance
physically
remodel
local
extracellular
matrix
(ECM).
We
also
identify
a
panel
soluble
proteins
contribute
chemotaxis,
such
as
TIMP-1
CXCL12.
Taken
together,
this
study
suggests
presence
cells
can
enhance
via
contractility,
independent
Language: Английский
Exploring the Potential of Mitochondria‐Targeted Drug Delivery for Enhanced Breast Cancer Therapy
International Journal of Breast Cancer,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Breast
cancer
stands
as
the
utmost
prevalent
malignancy
in
women,
impacting
epithelial
tissue
of
breast
and
often
displaying
resistance
to
effective
treatment
due
its
diverse
molecular
histological
features.
Current
modalities
may
exhibit
decreasing
efficacy
over
time
can
lead
disease
progression.
The
mitochondria,
a
crucial
organelle
responsible
for
cellular
metabolism
energy
supply,
stand
highly
sensitive
both
heat
reactive
oxygen
species,
presenting
an
assuring
target
photodynamic
photothermal
therapies
(PTTs)
cure.
employment
nanodrug
carriers
combination
deliveries
holds
promise
addressing
challenges
related
drug
degradation
off-target
toxicity.
By
circumventing
reticuloendothelial
system,
nanocarriers
bolster
drug's
bioavailability
at
intended
site
ensure
controlled
codelivery
multiple
drugs,
thereby
maintaining
normal
pharmacokinetic
features
regular
pharmacodynamic
characteristics
different
therapeutic
mechanisms.
precision
this
innovative
technology
have
revolutionized
delivery,
substantially
enhancing
effectiveness.
In
pursuit
targeting
mitochondrial
modifications
cells,
various
such
therapy
(PDT),
PTT,
chemodynamic
(CDT)
been
explored.
These
improved
efficiency
mitochondria-targeted
their
advantageous
properties
minimal
toxicity,
noninvasiveness,
reduced
resistance,
safer
profile.
Our
review
article
provides
exhaustive
overview
alterations
environment
BC,
impact
on
BC
development,
potential
targets
treatment,
nanotherapeutic
approaches
limitations
these
approaches.
Language: Английский
Glutamine metabolism model for predicting prognosis and immune infiltration in laryngeal squamous cell carcinoma
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 17, 2024
Abstract
Background
Laryngeal
cancer,
a
common
malignant
tumor
of
the
head
and
neck,
is
increasingly
prevalent
poses
significant
challenges
to
patient
health
quality
life.
The
primary
pathological
type
was
squamous
cell
carcinoma.
Previous
studies
have
shown
that
genes
involved
in
glutamine
metabolism
are
crucial
for
throat
cancer
development;
however,
their
prognostic
significance
laryngeal
remains
unexplored.
Methods
Data
from
patients
were
obtained
Cancer
Genome
Atlas
(TCGA),
(Gln)
metabolism-related
sourced
GeneCards
database.
Univariate
Cox
regression
analysis,
hub
gene
screening,
LASSO
identified
five
key
linked
LSCC
prognosis.
A
risk
score
calculated
on
basis
median
values
categorize
into
high-risk
low-risk
groups.
Clinical
features,
immune
infiltration,
immunotherapy
effects
systematically
analyzed.
Results
model
closely
correlated
with
model,
which
based
characteristic
genes,
demonstrated
excellent
predictive
performance,
as
validated
by
receiver
operating
(ROC)
curves
Kaplan‒Meier
survival
analysis.
Significant
differences
expression,
status
observed
among
different
Conclusion
This
can
effectively
predict
outcomes
infiltration
carcinoma
(LSCC)
patients.
Language: Английский
Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications
Ruiqi Chen,
No information about this author
Hongbiao Xu,
No information about this author
Elfira Jurat
No information about this author
et al.
Organ medicine.,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
ABSTRACT
Background
Ezrin,
a
member
of
the
ERM
protein
family,
has
emerged
as
pivotal
player
in
progression
diverse
tumor
types
and
exhibits
substantial
immunomodulatory
capabilities
inflammatory
disorders
tumor‐associated
immune
reactions.
Studies
have
validated
antitumor
efficacy
ezrin
inhibitors.
However,
comprehensive
pan‐cancer
analysis
to
fully
elucidate
functional
implications
not
been
performed.
Methods
Herein,
we
performed
multifaceted
database
investigation
evaluate
expression
patterns
relation
clinical
outcomes,
checkpoint
modulators,
prognostic
indicators,
genomic
profiles,
immunological
features.
Results
Our
revealed
distinct
across
various
cancers,
with
pronounced
association
between
cell
infiltration.
Furthermore,
drug
sensitivity
assessments
using
GDSC
CTRP
databases
underscored
robust
correlation
responsiveness
anticancer
agents,
highlighting
its
potential
therapeutic
target.
Notably,
also
correlated
patient
survival
outcomes
context
anti‐PD1
therapy
treatment,
suggesting
role
predictive
biomarker
for
blockade
therapies.
Conclusion
results
indicate
promising
target
valuable
diagnostic
marker
select
cancer
types.
intricate
mechanisms
underlying
involvement
responses
necessitate
further
in‐depth
harness
potential.
Language: Английский
Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients
Diabetology International,
Journal Year:
2024,
Volume and Issue:
15(4), P. 732 - 744
Published: July 26, 2024
Language: Английский
Glioblastoma Drives Protease-Independent Extracellular Matrix Invasion of Microglia
Published: Nov. 11, 2024
Glioblastoma
(GBM)
is
the
most
common
and
lethal
form
of
primary
brain
cancer.
Microglia
infiltration
into
tumor
microenvironment
associated
with
immunosuppression
poor
prognosis.
Improved
physicochemical
understanding
microglia
activation
invasion
may
provide
novel
GBM
therapeutic
strategies
essential
for
improving
long-term
treatment
efficacy.
Here,
we
combine
microfluidic
systems
3-D
collagen
hydrogels
to
systematically
investigate
activation,
invasion,
contractility
cytokine
secretion
in
response
GBM-microglia
crosstalk.
inflammatory
biomolecules
significantly
promote
3D
microglia.
Interestingly,
not
affected
by
inhibitors
MMP
activity
or
cellular
glycolysis.
In
contrast,
ROCK-pathway
inhibition
impedes
invasion.
Infrared
microscopy
analyses
show
that
co-culture
does
alter
lipid
content.
Further,
conditioned
media
resulted
increased
hydrogel
contraction,
suggesting
importance
physically
remodel
local
extracellular
matrix
(ECM).
We
also
identify
a
panel
soluble
proteins
contribute
chemotaxis,
such
as
TIMP-1
CXCL12.
Taken
together,
this
study
suggests
presence
cells
can
enhance
via
contractility,
independent
Language: Английский
Механізми та маркери метастазування при карциномах щитоподібної залози. Огляд літератури та власних даних (частина 1)
Endokrynologia,
Journal Year:
2024,
Volume and Issue:
29(3), P. 283 - 293
Published: Oct. 30, 2024
Резюме.
Огляд
літератури
присвячено
маркерам
та
механізмам
утворення
метастазів.
Акцент
робиться
на
відносно
маловивчених
процесах
–
ролі
жорсткості
пухлини
її
оточення,
участі
в
цих
асоційованих
із
пухлиною
фібробластів;
формування
преметастатичних
ніш,
переходу
дисемінованих
клітин
у
сплячий
стан
та,
особливо,
механізмам,
які
провокують
вихід
метастазів
цього
стану,
що
має
суттєве
практичне
значення.
Встановлено,
сайти
майбутніх
не
є
пасивними
приймачами
ракових
клітин,
а
вибірково
й
активно
модифікуються
первинною
ще
до
того,
як
відбулося
метастатичне
поширення.
Пухлини
індукують
мікрооточення
віддалених
органах,
яке
буде
сприяти
виживанню
росту
пухлинних
після
їх
засіву
метастатичні
сайти.
Підкреслюється
важливість
визначення
факторів,
сприяють
формуванню
ніш
при
карциномах
щитоподібної
залози
(ЩЗ).
Іноді,
замість
підвищують
ефективність
метастазування,
можуть
виникати
спеціалізовані
мікросередовища,
яких
пухлинні
клітини
виживають
стані
спокою.
Зараз
з’ясовуються
клітинні
молекулярні
складові
спокою
клітин.
Наведені
фактори,
спровокувати
зі
стану
Головна
увага
приділяється
метастазування
ЩЗ
трансформуючому
фактору
бета
(transforming
growth
factor
beta,
TGF-β),
матриксним
металопротеазам
(matrix
metalloproteinases,
ММРs),
фібробластів
19
(fibroblast
factors
19,
FGF19),
індукованому
гіпоксією
1α
(hypoxia-inducible
factors,
HIF-1α),
судинному
ендотеліальному
(vascular
endothelial
factor,
VEGF),
фібронектину,
інтегринам,
альфа-актину
гладких
м’язів
(α-smooth
muscle
actin,
α-SMA),
синдеканам,
кіназам
сімейства
Src,
осі
CXCL12/CXCR4,
стовбурових
ін.
Особливий
інтерес
викликають
маркери,
можна
виявити
плазмі
крові
методом
тонкоголкової
біопсії
доопераційний
період.